Addex EBITDA from 2010 to 2023

ADXN Stock

USD 0.69 0.0397 6.11%

Addex Therapeutics Earnings Before Interest Taxes and Depreciation Amortization EBITDA yearly trend continues to be very stable with very little volatility. Earnings Before Interest Taxes and Depreciation Amortization EBITDA are likely to drop to -20,698,544. During the period from 2010 to 2023, Addex Therapeutics Earnings Before Interest Taxes and Depreciation Amortization EBITDA quarterly data regression pattern had range of 19,276,856 and median of (3,219,807). Addex Therapeutics Gross Profit is very stable at the moment as compared to the past year. Addex Therapeutics reported last year Gross Profit of 1.42 Million. As of 1st of June 2023, Revenues is likely to grow to about 2.2 M, while Consolidated Income is likely to drop (21.4 M).

Check Addex Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Addex main balance sheet or income statement drivers, such as Gross Profit of 2.2 M, Interest Expense of 310.2 K or Operating Expenses of 19.9 M, as well as many exotic indicators such as Asset Turnover of 0.12, Book Value per Share of 0.8 or Current Ratio of 2.45. Addex financial statements analysis is a perfect complement when working with Addex Therapeutics Valuation or Volatility modules. It can also supplement various Addex Therapeutics Technical models . Check out the analysis of Addex Therapeutics Correlation against competitors. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

Addex EBITDA Breakdown

Showing smoothed Earnings Before Interest Taxes and Depreciation Amortization EBITDA of Addex Therapeutics with missing and latest data points interpolated. EBITDA is a non-GAAP accounting metric that is widely used when assessing the performance of companies; calculated by adding Depreciation Amortization and Accretion back to Earning Before Interest and Taxes EBIT.Addex Therapeutics' Earnings Before Interest Taxes and Depreciation Amortization EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Addex Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported (20.17 M)

10 Years Trend

Compare to Others All Fundamentals

Earnings Before Interest Taxes and Depreciation Amortization EBITDA

Timeline

Addex EBITDA Regression Statistics

	Arithmetic Mean	(7,789,317)
	Geometric Mean	5,385,085
	Coefficient Of Variation	(89.83)
	Mean Deviation	6,131,959
	Median	(3,219,807)
	Standard Deviation	6,997,052
	Range	19,276,856
	R-Value	(0.83)
	R-Squared	0.68
	Significance	0.00026701
	Slope	(1,382,604)

Addex EBITDA History

	2023	-20.7 M
	2022	-20.2 M
	2021	-14.9 M
	2020	-11.8 M
	2019	-14.2 M
	2018	-1.4 M

Other Fundumenentals of Addex Therapeutics

	EBITDA Margin
	Enterprise Value over EBITDA

Addex Therapeutics EBITDA component correlations

About Addex Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Addex Therapeutics income statement, its balance sheet, and the statement of cash flows. Addex Therapeutics investors use historical funamental indicators, such as Addex Therapeutics's EBITDA, to determine how well the company is positioned to perform in the future. Although Addex Therapeutics investors may use each financial statement separately, they are all related. The changes in Addex Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Addex Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Addex Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Addex Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for 2023
EBITDA Margin	(14.18)	(14.55)
Enterprise Value over EBITDA	0.28	0.31
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	-20.2 M	-20.7 M

Be your own money manager

Our tools can tell you how much better you can do entering a position in Addex Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency

All Next

Launch Module

Pair Trading with Addex Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Addex Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Addex Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Addex Stock

+	0.71	EQ	Equillium	Fiscal Quarter End 30th of June 2023	Pair Corr
+	0.71	KA	Kineta Inc	Symbol Change	Pair Corr
+	0.8	YS	YS Biopharma	Report 2nd of June 2023	Pair Corr

Moving against Addex Stock

	-	0.48	VBLT	Vascular Biogenics		Fiscal Quarter End 30th of June 2023	Pair Corr
	-	0.44	VECT	VectivBio Holding		Report 19th of July 2023	Pair Corr

The ability to find closely correlated positions to Addex Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Addex Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Addex Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Addex Therapeutics to buy it.

The correlation of Addex Therapeutics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Addex Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Addex Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Addex Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Check out the analysis of Addex Therapeutics Correlation against competitors. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide. You can also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.

	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	ETF Directory Find actively traded Exchange Traded Funds (ETF) from around the world

Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.41)

Revenue Per Share

0.192

Quarterly Revenue Growth

0.493

Return On Assets

(0.83)

Return On Equity

(1.90)

The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out the analysis of Addex Therapeutics Correlation against competitors. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

	Total Assets	Current Assets	Cash and Equivalents	Total Debt	Debt Current	Deferred Revenue	Investments Current	Total Liabilities	Current Liabilities
Total Assets		1.0	1.0	0.03	-0.15	-0.39	0.21	0.7	0.66
Current Assets	1.0		1.0	0.04	-0.14	-0.37	0.21	0.69	0.65
Cash and Equivalents	1.0	1.0		0.06	-0.12	-0.36	0.2	0.68	0.64
Total Debt	0.03	0.04	0.06		0.81	0.71	0.36	-0.24	-0.39
Debt Current	-0.15	-0.14	-0.12	0.81		0.96	-0.2	-0.53	-0.58
Deferred Revenue	-0.39	-0.37	-0.36	0.71	0.96		-0.32	-0.69	-0.72
Investments Current	0.21	0.21	0.2	0.36	-0.2	-0.32		0.39	0.24
Total Liabilities	0.7	0.69	0.68	-0.24	-0.53	-0.69	0.39		0.98
Current Liabilities	0.66	0.65	0.64	-0.39	-0.58	-0.72	0.24	0.98

Addex EBITDA from 2010 to 2023

Addex EBITDA Breakdown

Addex EBITDA Regression Statistics

Addex EBITDA History

Other Fundumenentals of Addex Therapeutics

Addex Therapeutics EBITDA component correlations

About Addex Therapeutics Financial Statements

Be your own money manager

Did you try this?

Run Cryptocurrency Center Now

Cryptocurrency Center

Pair Trading with Addex Therapeutics

Moving together with Addex Stock

Moving against Addex Stock

Complementary Tools for Addex Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY